| Application no. and date | 19765711.7 (espacenet) (Federated) (European Patent Register), 20190906 | | Patent/reg. no. and date | DK/EP 3847157, 20220518 | | Publication date | 20210714 | | Priority no. and date | EP 18306177, 20180907 | | EP pub. no. and date |
EP 3847157 20210714 | | Effective date | | | Applicant/owner | Sanofi, 46 Avenue de la Grande Armée
75017 Paris, FR | | Applicant ref. no. | 1625775 | | Inventor | RABION, Alain, Sanofi - Patent Department 54 rue La Boétie
75008 Paris, FR,
TABART, Michel, Sanofi - Patent Department 54 rue La Boétie
75008 Paris, FR,
WEHREY, Christian, Sanofi - Patent Department 54 rue La Boétie
75008 Paris, FR | | Representative | RWS Group, RWS Compass House
Vanwall Business Park, Vanwall Road
Maidenhead, Berkshire
SL6 4UB
, GB | | Opponent | | | IPC Class | C07D 207/12 (2006.01) | | Title | FREMGANGSMÅDE TIL FREMSTILLING AF METHYL-[6-(2,4-DICHLORPHENYL)-5-[4-[(3S)-1-(3-FLUORPROPYL)PYRROLIDIN-3-YL]OXYPHENYL]-8,9-DIHYDRO-7H-BENZO[7]ANNULEN-2-CARBOXYLAT] OG SALT DERAF | | Int. application no. | EP2019073827 | | Int. publication no. | WO2020049153 | | Related patent (certificate) | | | Status | DK/EP patent | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
